Pages that link to "Q35863376"
Jump to navigation
Jump to search
The following pages link to Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study (Q35863376):
Displaying 9 items.
- A plant-expressed conjugate vaccine breaks CD4( ) tolerance and induces potent immunity against metastatic Her2( ) breast cancer (Q37078963) (← links)
- Challenges in vaccine therapy in hematological malignancies and strategies to overcome them (Q38843235) (← links)
- Is immunotherapy here to stay in multiple myeloma? (Q39084427) (← links)
- Linked CD4 T Cell Help: Broadening Immune Attack Against Cancer by Vaccination (Q49013708) (← links)
- Trial watch: DNA-based vaccines for oncological indications (Q56893452) (← links)
- Cancer DNA vaccines: current preclinical and clinical developments and future perspectives (Q64072806) (← links)
- Idiotype-specific CD4( ) T cells eradicate disseminated myeloma (Q86423514) (← links)
- scFv6.C4 DNA vaccine with fragment C of Tetanus toxin increases protective immunity against CEA-expressing tumor (Q91637287) (← links)
- scFv6.C4 DNA vaccine with fragment C of tetanus toxin increases protective immunity against CEA-expressing tumor (Q96126755) (← links)